- Home
- ZYXI
ZYXI
Zynex Inc.
as 11-08-2024 12:38pm EST
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | ENGLEWOOD |
| Market Cap: | 257.1M | IPO Year: | N/A |
| Target Price: | $14.00 | AVG Volume (30 days): | 120.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.15 | EPS Growth: | -66.20 |
| 52 Week Low/High: | $7.15 - $13.77 | Next Earning Date: | 10-24-2024 |
| Revenue: | $193,665,000 | Revenue Growth: | 4.21% |
| Revenue Growth (this year): | 10.7% | Revenue Growth (next year): | 19.78% |
Stock Insider Trading Activity of Zynex Inc. (ZYXI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sandgaard Thomas | ZYXI | PRESIDENT, CEO AND CHAIRMAN | Nov 4 '24 | Sell | $8.51 | 6,000 | $51,080.00 | 14,619,350 | |
| MOORHEAD DANIEL J | ZYXI | CHIEF FINANCIAL OFFICER | Nov 1 '24 | Sell | $8.59 | 10,000 | $85,900.00 | 44,878 | |
| Sandgaard Thomas | ZYXI | PRESIDENT, CEO AND CHAIRMAN | Oct 30 '24 | Sell | $8.79 | 6,000 | $52,740.00 | 14,619,350 |
Latest Zynex Inc. News
ZYXI Breaking Stock News: Dive into ZYXI Ticker-Specific Updates for Smart Investing
Simply Wall St.
8 days ago
Zynex's (NASDAQ:ZYXI) Soft Earnings Are Actually Better Than They Appear
Simply Wall St.
13 days ago
Zynex Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Thomson Reuters StreetEvents
14 days ago
Q3 2024 Zynex Inc Earnings Call
GuruFocus.com
14 days ago
Zynex Inc (ZYXI) Q3 2024 Earnings Call Highlights: Navigating Growth and Challenges
Zacks
15 days ago
Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates
PR Newswire
15 days ago
Zynex Reports Third Quarter 2024 Financial Results
PR Newswire
23 days ago
Zynex Sets Third Quarter 2024 Earnings Call
TipRanks
a month ago
Zynex price target lowered to $11 from $12 at RBC Capital
Compare ZYXI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ZYXI Zynex Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.